Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Houda Kaabi"'
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 10, Iss 11, Pp n/a-n/a (2022)
Abstract Background Minor histocompatibility antigens (mHAgs) are endogenous immunogenic peptides initially identified due to complications detected in several contexts of HLA geno‐identical hematopoietic stem cell transplantation (HSCT). In this s
Externí odkaz:
https://doaj.org/article/c5cac86e0f4a4de48b46b9773b45299d
Autor:
Mohamed Hichem Sellami, Lamia Torjemane, Alejandro Espadas de Arias, Houda Kaabi, Saloua Ladeb, Francesca Poli, Tarek Ben Othmane, Slama Hmida
Publikováno v:
Clinics, Vol 65, Iss 11, Pp 1099-1103 (2010)
INTRODUCTION: Minor histocompatibility antigen HA-1 (MiHAg-HA-1) disparity between a patient and his or her human leukocyte antigen (HLA) genoidentical donor has been widely associated with an increased risk of graft-versus-host disease following all
Externí odkaz:
https://doaj.org/article/ee9c381d0239426a9ee0f730d35b8e45
Publikováno v:
La Tunisie medicale. 97(2)
The diagnosis and the treatment of rare phenotypes remain a problematic situation in many countries especially in Tunisia. Individuals with rare phenotype may develop clinically significant red cell antibodies directed against the high incidence Anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::60213a30512d0f706ea029d9f12f20aa
https://pubmed.ncbi.nlm.nih.gov/31539100
https://pubmed.ncbi.nlm.nih.gov/31539100
Autor:
Houda Kaabi, Capucine Picard, Monia Ben Khaled, Fethi Mellouli, Monia Ouederni, Mohamed Bejaoui
Publikováno v:
Journal of Clinical Immunology. 36:437-440
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d88fcbcb5729fc6422ee22a889977b2
https://doi.org/10.1007/s10875-016-0293-2
https://doi.org/10.1007/s10875-016-0293-2
Autor:
Sonia, Mahjoub, Héla, Baccouche, Mariam, Sahnoun, Houda, Kaabi, Zeineb, Manai, Hmida, Slama, Neila, Ben Romdhane
Publikováno v:
La Tunisie medicale. 93(7)
BCR-ABL negative myeloproliferative neoplasms (MPN) include polycythemia Vera (PV), essential thrombocythemia (ET) and primitive myelofibrosis (PMF). the JAK2 V617F mutation has been introduced since 2008 as a major diagnostic criterion on the one ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e627ab28f65c92b88c22f2efb08b3b0a
https://pubmed.ncbi.nlm.nih.gov/26757507
https://pubmed.ncbi.nlm.nih.gov/26757507
Autor:
Houda Kaabi, Hager Zarruk, Hedi Bellali, Asma Mahfoudh, Chaima Amdouni, Nejia Chalfouh, Slama Hmida
Publikováno v:
Transfusion Clinique et Biologique. 24:340
Introduction Les sujets de phenotype « p », dont la frequence est de 0,0005 % des caucasiens, developpent un anticorps anti-PP1Pk encore appele anti-Tja. Cet anticorps est a l’origine d’hemolyse immediate post-transfusionnelle et d’avortement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f78ec5a24f513aa5beb9657b2ac0372d
https://doi.org/10.1016/j.tracli.2017.06.183
https://doi.org/10.1016/j.tracli.2017.06.183
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Baccouche, Héla, Labidi, Asma, Fekih, Monia, Mahjoub, Sonia, Houda Kaabi, Hmida, Slama, Filali, Azza, Romdhane, Neila B.
Publikováno v:
Blood Coagulation & Fibrinolysis; Mar2017, Vol. 28 Issue 2, p139-144, 6p